Follow the 휴젤 share price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on KR KR, under the supervision of DART (FSS). Operating in the Health Care sector, 휴젤 has logged 39 reports. Market capitalisation: €2,636bn. The latest transaction was disclosed on 2 July 2026 (Other). Among the most active insiders: 아프로디테애퀴지션홀딩스엘엘씨. Every trade is free.
39
Insider Decl.
0
Thresholds
€11,681
2 ops.
Buy Volume
·
11 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate 휴젤 Strong Buy (bullish), based on 15 analysts. Average price target: ₩359,867.
23Σ signal
Buys €11,681· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 2,455 of 25,791 companies
74.2
score / 100
Value
59
Quality
89
FCF yld4.6%
Earn yld5.4%
EV/EBITDA12.1x
ROE16%
Gross mgn78%
Net mgn33%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
휴젤 is a South Korean company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on the development and commercialization of pharmaceutical products and medical devices.